Ido Solt

Ido Solt

Auto-generated profile, based on publicly available information

Ido Solt

Department of Obstetrics and Gynecology Rambam Health Care Campus Haifa Israel

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
MGMeadow M. Do Good
Meadow M. Do Good
ISIdo Solt
Ido Solt
JAJoann G. Acuna
Joann G. Acuna
SRSiegfried Rotmensch
Siegfried Rotmensch
MKMatthew J. Kim
Matthew J. Kim
OBJECTIVE: To report the demographic characteristics and clinical morbidity of methamphetamine-exposed pregnancies compared with control patients in a tertiary care, urban, academic medical center. METHODS: A single-site chart review from 2000 to 2006 was conducted. International Classification of Diseases, 9th Revision code 648.3x was used to identify potential study participants. Specific inclusion criteria required either a positive urine drug screen for methamphetamine use or by patient statement of methamphetamine use during pregnancy. Data from 276 identified patients were then compared with the 34,055 in the general obstetric population during the same period for various demographic factors and perinatal outcomes. RESULTS: Two hundred seventy-six patients responsible for 273 live births were identified between 2000 and 2006. Factors that were significantly associated with methamphetamine use were age younger than 20 years (9% methamphetamine compared with 16% control patients), non-Hispanic white ethnicity (55% compared with 71%), married (12% compared with 46%), preterm delivery (52% compared with 17%), low Apgar scores (6% compared with 1–2%), cesarean delivery (29% compared with 23%), and neonatal mortality (4% compared with 1%). Additionally, the maternal demographic characteristics suggested that these women were more likely to be unemployed, use other abusive substances, and have higher rates of domestic violence and adoption when compared with the control population. CONCLUSION: Methamphetamine use in pregnancy is complicated by more morbid maternal and neonatal outcomes when compared with the general obstetric population. Because the patients in this study were in a variety of ways demographically distinct, attempts to identify these patients early and intervene in an effort to improve pregnancy-related outcomes appears possible and warranted. LEVEL OF EVIDENCE: II

22 February 2023 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
AAAnat Aharon
Anat Aharon
ARAnnie Rebibo-Sabbah
Annie Rebibo-Sabbah
RARawan Sayed Ahmad
Rawan Sayed Ahmad
ADAyelet Dangot
Ayelet Dangot
TBTali Hana Bar-Lev
Tali Hana Bar-Lev
ISIdo Solt
Ido Solt
Introduction: Gestational vascular complications (GVCs), including gestational hypertension and preeclampsia, are leading causes of maternal morbidity and mortality. Elevated levels of extracellular vesicles (EVs), in GVC have been linked to vascular injury. This study aims to characterize placental and circulating EV miRNA in GVCs, and explores the involvement of EV-miRNA in GVC, and whether they may be used to distinguish between placental and maternal pathologies.Methods: Blood samples were obtained from 15 non-pregnant (NP), 18 healthy-pregnant (HP), and 23 women with GVC during the third trimester. Placental sections were obtained after caesarian section. Platelet-poor-plasma (PPP) and EV pellets were characterized: EV size/concentration, protein content and miRNA expression were measured by nanoparticle tracking analysis, western blot, nano-string technology and RT-PCR. The effects of EVs on trophoblasts and EC miRNA expression were evaluated.Results: Higher EVs concentrations were observed in HP-PPP and GVC-PPP (p < 0.0001) compared to the NP-PPP. The concentration of large EVs (>100 nm) was higher in PPP and EV pellets of HP and GVC compared to the NP group. EV pellets of pregnant women demonstrated lower expression of exosomal markers CD63/CD81 compared to NP-EVs. GVC-EVs expressed more human placental lactogen (hPL) hormone than HP-EVs, reflecting their placental origin. Screening of miRNAs in EV pellets and in PPP identified certain miRNAs that were highly expressed only in EVs pellets of the HP (13%) and GVC groups (15%), but not in the NP group. Differences were detected in the expression of hsa-miR-16-5p, hsa-miR-210, and hsa-miR-29b-3p. The expression of hsa-miR-16-5p and hsa-miR-210 was low in EV pellets obtained from NP, higher in HP-EVs, and significantly lower in GVC-EVs. Except for hsa-miR-29b-3p, which was upregulated in GVC, no significant differences were found in the levels of other miRNAs in placental sections. Exposure to GVC-EVs resulted in higher expression of hsa-miR-29b-3p compared to cells exposed to HP-EVs in villous trophoblasts, but not in EC.Conclusion: Expression of hsa-miR-16-5p and hsa-miR-210 reflects maternal pathophysiological status, while hsa-miR-29b-3p reflects placental status. These findings suggest that EV-miRNA are involved in GVC, and that they may be used to distinguish between pathologies of placental and maternal origins in preeclampsia.

1 May 2011 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ISIdo Solt
Ido Solt
SJSherri Jackson
Sherri Jackson
TMThomas Moore
Thomas Moore
SRSiegfried Rotmensch
Siegfried Rotmensch
MKMatthew J. Kim
Matthew J. Kim

1 December 2011 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
ISIdo Solt
Ido Solt
JAJoann G. Acuna
Joann G. Acuna
BABeni A. Adeniji
Beni A. Adeniji
JMJames Mirocha
James Mirocha
MKMatthew J. Kim
Matthew J. Kim
SRSiegfried Rotmensch
Siegfried Rotmensch
Objectives The purpose of this study was to examine the efficacy of nonvisualization of the fourth ventricle for first‐trimester detection of spina bifida. Methods A total of 250 digitally stored sonographic examinations at gestational ages of 11 weeks to 13 weeks 6 days (245 normal and 5 randomly interspersed spina bifida cases) were retrospectively analyzed by 4 blinded reviewers for the presence or absence of the fourth ventricle followed by an anteroposterior ventricular dimension measurement. The ventricle size was related to the crown‐rump length and gestational age by linear regression analysis and Pearson correlation. Results The fourth ventricle was identified in 971 of 1000 image readings (97.1%). False‐negative and false‐positive readings occurred in 11 of 20 (55.0%) and 20 of 980 (2.0%) cases, respectively (sensitivity, 0.45; specificity, 0.98.). False‐negative and false‐positive readings were evenly distributed throughout the gestational age range. When the ventricular size was measurable, its mean dimensions increased linearly with gestational age and were below the fifth percentile in 10 of 245 (4.0%) normal and 0 of 4 spina bifida cases, respectively. Intraclass correlation coefficient estimates were calculated based on the 2‐way analysis of variance model and found to be 0.30 for a single rater and 0.64 for the mean of 4 raters. Conclusions Nonvisualization of the first‐trimester fourth ventricle is a less robust screening parameter for spina bifida than previously published.

29 June 2000 in Medical and Pediatric Oncology
Verified
Journal Article
Closed access
ISIdo Solt
Ido Solt
DGDiana Gaitini
Diana Gaitini
MPMenucha Pery
Menucha Pery
ZHZeev Hochberg
Zeev Hochberg
MSMoshe Stein
Moshe Stein
MAMyriam Weyl Ben Arush
Myriam Weyl Ben Arush

9 October 2007 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
EOElla Ophir
Ella Ophir
ASAvshalom Strulov
Avshalom Strulov
ISIdo Solt
Ido Solt
RMRosa Michlin
Rosa Michlin
IBIgor Buryanov
Igor Buryanov
Jacob BornsteinJacob Bornstein
Jacob Bornstein